Ehave is a leading healthcare services and technology company, focused on progressing Psychedelics-to-Therapeutics by engineering novel compounds and new treatment protocols for treating brain health.
Together with our network of scientists and mental health professionals, we are on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues, leveraging clinical data to help us achieve optimal patient outcomes.
Ehave’s operations span across the entire USA, Canada, Jamaica, and Australia.
